Login Register
icon_bulk_orderBulk order Acrobiosystems for English
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Non SARS-Cov-2 Kits > BCMA > EP-127

BCMA [Biotinylated] : APRIL Inhibitor Screening Chemiluminescence Assay Kit

For research use only.
IDComponentsSize
EP127-C01High-bind Plate1plate
EP127-C02Human APRIL 10μg
EP127-C03Biotinylated Human BCMA10μg
EP127-C04Anti-BCMA Neutralizing Antibody40μg
EP127-C05Streptavidin-HRP10μg
EP127-C06Coating Buffer12mL
EP127-C0710xWashing Buffer 50mL
EP127-C08Blocking Buffer50mL
EP127-C09-AELISA Femto Substrate A6mL
EP127-C09-BELISA Femto Substrate B6mL
  • Background
    BCMA (B cell maturation antigen), a member of the tumor necrosis factor receptor family. BCMA is mainly expressed on the surface of advanced B cells, short-lived proliferating plasmablasts and long-lived plasma cells, but not in naive B cells, CD34-positive hematopoietic stem cells and other normal tissue cells. With its specific expression ability, BCMA has become a good diagnostic marker and therapeutic target for multiple myeloma (MM).The main ligands of BCMA are BAFF and APRIL. When BCMA was combined with APRIL, the expression level of immune checkpoint was up-regulated to create an immunosuppressive bone marrow microenvironment. APRIL, as an important ligand of BCMA, is a member of the TNF(Tumor necrosis factor) receptor family (TNFSF-13A), which has 30% sequence homology with BAFF, another ligand of BCMA. But it has a higher affinity to interact with BCMA. It consists of 250 amino acids, of which 28 amino acids encode intracellular regions and 201 amino acids encode type II transmembrane proteins and their extracellular regions. The binding of APRIL to BCMA also induces both classical and non-classical NF-κB pathways, further promoting angiogenesis and metastasis, as well as tumor cell growth and proliferation.
  • Application
    This kit is developed for screening for inhibitors of human BCMA binding to human APRIL.

    It is for research use only.

  • Reconstitution
    Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.
  • Storage
    The unopened kit is stable for 12 months from the date of manufacture if stored at 2°C to 8°C.

    The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

  • Assay Principles
    This inhibitor screening Assay kit is designed to facilitate the identification and characterization of new BCMA pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human BCMA to immobilized human APRIL in a functional chemiluminescence assay. Briefly, we provide you with a human Biotinylated BCMA protein, a human APRIL protein, an anti-BCMA neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.

    Your experiment will include 4 simple steps:

    a) Coat the plate with human APRIL.

    b) Add your molecule of interest to the tests.

    c) Add human BCMA-Biotin to bind the coated human APRIL.

    d) Add Streptavidin-HRP followed by luminol.

    Finally, the ability of your compound to inhibit APRIL: BCMA binding will be determined by comparing OD readings among different experimental groups.

Typical Data
 BCMA ELISA

INHIBITION OF BCMA [BIOTINYLATED]: APRIL BINDING BY ANTI-BCMA NEUTRALIZING ANTIBODY
Serial dilutions of Anti-BCMA Neutralizing antibody (Catalog # EP127-C04) (1:1 serial dilution, from 20 μg/mL to 0.01μg/mL) was added into Biotinylated BCMA: APRIL binding reactions. The assay was performed according to the protocol described below. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).

Comments (0)


ETD of in-stock products: 2 business days

Price(USD) : $650.00

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:2 Details
  • Number of Drugs in Clinical Trials:58 Details
  • Latest Research Phase:Approved

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Contact Us

+1  800-810-0816 (US)
+86 400-682-2521 (AP)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop
Call us
Call us
North America: +1 800-810-0816 (Toll Free)
Asia & Pacific: +86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message